This protocol is judged by an institutional review board, an impartial group that evaluations any medical trials involving individuals. If a examine requires a Agenda I drug, after the board approves the protocol as ethical, the researchers should apply for an investigational new drug (IND) number from the FDA.Fortunately, other providers with work